JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WWE
1851
DELISTED
World Wrestling Entertainment
WWE
| $11.5M | ﹤0.01% |
318,924
-151,631
| -32% | -$5.34M |
2016 Q4
5 quarters
|
|
1852
PUT
Stanley Black & Decker
SWK
$13.5B
| $11.5M | ﹤0.01% |
74,800
| – | – |
2017 Q3
2 quarters
|
|
1853
Sumitomo Mitsui Financial
SMFG
$160B
| $11.4M | ﹤0.01% |
1,346,981
+102,862
| +8% | +$919K |
2013 Q2
19 quarters
|
|
1854
PUT
IBM
IBM
$213B
| $11.4M | ﹤0.01% |
77,822
-10,356
| -12% | -$1.57M |
2015 Q3
10 quarters
|
|
1855
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.4B
| $11.4M | ﹤0.01% |
212,682
-59,740
| -22% | -$3.22M |
2013 Q2
19 quarters
|
|
1856
Myriad Genetics
MYGN
$388M
| $11.4M | ﹤0.01% |
385,720
+105,863
| +38% | +$3.58M |
2013 Q2
19 quarters
|
|
1857
Flowers Foods
FLO
$1.18B
| $11.3M | ﹤0.01% |
518,772
+38,385
| +8% | +$775K |
2013 Q2
19 quarters
|
|
|
SEM
1858
DELISTED
Select Medical
SEM
| $11.3M | ﹤0.01% |
1,219,559
+210,567
| +21% | +$2M |
2015 Q2
11 quarters
|
|
1859
PUT
RTX Corp
RTX
$249B
| $11.3M | ﹤0.01% |
143,010
-15,413
| -10% | -$1.27M |
2014 Q3
14 quarters
|
|
1860
iShares Morningstar US Equity ETF
ILCB
$1.3B
| $11.3M | ﹤0.01% |
295,188
-272
| -0.1% | -$10.9K |
2013 Q2
19 quarters
|
|
|
KEM
1861
DELISTED
KEMET Corporation
KEM
| $11.3M | ﹤0.01% |
623,591
-506,087
| -45% | -$9.26M |
2017 Q2
3 quarters
|
|
1862
CALL
Adobe
ADBE
$95.9B
| $11.3M | ﹤0.01% |
52,300
-8,400
| -14% | -$1.71M |
2017 Q1
4 quarters
|
|
|
CMTA
1863
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $11.3M | ﹤0.01% |
744,869
+38,572
| +5% | +$628K |
2017 Q3
2 quarters
|
|
1864
CALL
Phillips 66
PSX
$105B
| $11.3M | ﹤0.01% |
117,300
-132,100
| -53% | -$12.9M |
2016 Q4
5 quarters
|
|
1865
Axalta
AXTA
$6.82B
| $11.2M | ﹤0.01% |
372,507
-17,374
| -4% | -$543K |
2015 Q3
10 quarters
|
|
1866
NewMarket
NEU
$8.47B
| $11.2M | ﹤0.01% |
27,979
+2,164
| +8% | +$881K |
2013 Q2
19 quarters
|
|
1867
Helmerich & Payne
HP
$3.82B
| $11.2M | ﹤0.01% |
168,673
-33,358
| -17% | -$2.25M |
2013 Q2
19 quarters
|
|
1868
Nexa Resources
NEXA
$1.56B
| $11.2M | ﹤0.01% |
640,923
+20,282
| +3% | +$399K |
2017 Q4
1 quarter
|
|
1869
CALL
Mondelez International
MDLZ
$73.7B
| $11.2M | ﹤0.01% |
268,400
-118,100
| -31% | -$5.13M |
2014 Q3
14 quarters
|
|
1870
Kite Realty
KRG
$4.9B
| $11.2M | ﹤0.01% |
735,144
+58,003
| +9% | +$939K |
2013 Q2
19 quarters
|
|
1871
Agree Realty
ADC
$8.09B
| $11.2M | ﹤0.01% |
232,891
+59,087
| +34% | +$2.84M |
2013 Q2
19 quarters
|
|
1872
Commault Systems
CVLT
$6.12B
| $11.2M | ﹤0.01% |
195,601
-67,578
| -26% | -$3.64M |
2013 Q2
19 quarters
|
|
1873
iShares US Medical Devices ETF
IHI
$3.46B
| $11.2M | ﹤0.01% |
362,610
+304,560
| +525% | +$9.38M |
2015 Q4
9 quarters
|
|
1874
Community Trust Bancorp
CTBI
$1.37B
| $11.1M | ﹤0.01% |
246,644
-14,246
| -5% | -$662K |
2013 Q2
19 quarters
|
|
1875
Cracker Barrel
CBRL
$1.16B
| $11.1M | ﹤0.01% |
69,786
+14,472
| +26% | +$2.4M |
2013 Q2
19 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.